The government could save billions by circumventing the regulatory process and funding unapproved health interventions. Of course, it does not do this because of the obvious risk to patient safety and public confidence in the health system. Why now?
This has happened before and the response should be the same. No.
October 17, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Weight loss medicines drive revenue sales growth for Sigma and Wesfarmers Health
August 28, 2026 - - BioPharma -
Patients Australia put healthcare’s quiet achievers in the spotlight
August 28, 2026 - - Latest News -
Cheaper medicines save Australians $1.4 billion as pharmacists urge freeze for all patients
August 28, 2026 - - Latest News -
Mayne Pharma bets on women’s health and direct distribution after a difficult year
August 28, 2026 - - Latest News -
Cathy Freeman to headline 2026 Patient’s Choice Awards
August 27, 2026 - - Latest News -
Australian company secures Mitsubishi partnership to bring BioPQQ to market
August 26, 2026 - - Latest News -
Noxopharm pushes Sofra platform towards cancer proof of concept
August 26, 2026 - - Australian Biotech
